Shares of Insmed Incorporated (NASDAQ: INSM), a pharmaceutical company, have risen sharply in trading today after the company announced the lifting of clinical hold by FDA on ARIKACE® in Cystic Fibrosis (CF) patients with Pseudomonas lung infections.
[...]
Recent Comments